(Q39351791)

11 September 2017

title

Apigenin induces apoptosis and blocks growth of medroxyprogesterone acetate-dependent BT-474 xenograft tumors (English)

1 reference

11 September 2017

1 reference

Benford Mafuvadze

1

1 reference

11 September 2017

Yayun Liang

2

1 reference

11 September 2017

Cynthia Besch-Williford

3

1 reference

11 September 2017

Xu Zhang

4

1 reference

11 September 2017

Salman M Hyder

5

1 reference

11 September 2017

publication date

9 May 2012

1 reference

11 September 2017

1 reference

11 September 2017

volume

3

1 reference

11 September 2017

issue

4

1 reference

11 September 2017

page(s)

160-171

1 reference

Hormone replacement therapy and the risk of breast cancer

11 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS12672-012-0114-X

Effect of hormone replacement therapy on breast cancer risk: estrogen versus estrogen plus progestin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12672-012-0114-X

Postmenopausal hormone therapy and breast cancer: an uncertain trade-off

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12672-012-0114-X

Progestin regulation of cellular proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12672-012-0114-X

Pharmacological and endogenous progestins induce vascular endothelial growth factor expression in human breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12672-012-0114-X

Trends in menopausal hormone therapy use of US office-based physicians, 2000-2009

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12672-012-0114-X

The decrease in breast-cancer incidence in 2003 in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12672-012-0114-X

Recent trends in hormone therapy utilization and breast cancer incidence rates in the high incidence population of Marin County, California

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12672-012-0114-X

Recent declines in hormone therapy utilization and breast cancer incidence: clinical and population-based evidence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12672-012-0114-X

Progesterone induces adult mammary stem cell expansion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12672-012-0114-X

Progesterone receptors--animal models and cell signalling in breast cancer. Diverse activation pathways for the progesterone receptor: possible implications for breast biology and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12672-012-0114-X

Osteoclast differentiation factor RANKL controls development of progestin-driven mammary cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12672-012-0114-X

RANK ligand mediates progestin-induced mammary epithelial proliferation and carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12672-012-0114-X

Amphiregulin mediates estrogen, progesterone, and EGFR signaling in the normal rat mammary gland and in hormone-dependent rat mammary cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12672-012-0114-X

Apigenin prevents development of medroxyprogesterone acetate-accelerated 7,12-dimethylbenz(a)anthracene-induced mammary tumors in Sprague-Dawley rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12672-012-0114-X

Progestin-dependent progression of human breast tumor xenografts: a novel model for evaluating antitumor therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12672-012-0114-X

Synthetic progestins induce growth and metastasis of BT-474 human breast cancer xenografts in nude mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12672-012-0114-X

Effect of antiprogestins and tamoxifen on growth inhibition of MCF-7 human breast cancer cells in nude mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12672-012-0114-X

Evaluation of Ki-67 proliferation and apoptotic index before, during and after neoadjuvant chemotherapy for primary breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12672-012-0114-X

PIK3CA mutations correlate with hormone receptors, node metastasis, and ERBB2, and are mutually exclusive with PTEN loss in human breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12672-012-0114-X

Apigenin Induces Apoptosis through Proteasomal Degradation of HER2/neu in HER2/neu-overexpressing Breast Cancer Cells via the Phosphatidylinositol 3-Kinase/Akt-dependent Pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12672-012-0114-X

Inhibition of the 26S proteasome blocks progesterone receptor-dependent transcription through failed recruitment of RNA polymerase II.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12672-012-0114-X

Inhibition of proteasome activity by the dietary flavonoid apigenin is associated with growth inhibition in cultured breast cancer cells and xenografts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12672-012-0114-X

Effects of Chinese Jianpi herbs on cell apoptosis and related gene expression in human gastric cancer grafted onto nude mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12672-012-0114-X

Apigenin-induced-apoptosis is mediated by the activation of PKCdelta and caspases in leukemia cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12672-012-0114-X

Apigenin induced apoptosis through p53-dependent pathway in human cervical carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12672-012-0114-X

HER2 regulates the mammary stem/progenitor cell population driving tumorigenesis and invasion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12672-012-0114-X

Specific blockade of VEGF and HER2 pathways results in greater growth inhibition of breast cancer xenografts that overexpress HER2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12672-012-0114-X

Proliferation of endothelial and tumor epithelial cells by progestin-induced vascular endothelial growth factor from human breast cancer cells: paracrine and autocrine effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12672-012-0114-X

Vascular endothelial growth factor (VEGF) upregulates BCL-2 and inhibits apoptosis in human and murine mammary adenocarcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12672-012-0114-X

Progestins in hormone replacement therapies reactivate cancer stem cells in women with preexisting breast cancers: a hypothesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12672-012-0114-X

Apigenin inhibits pancreatic cancer cell proliferation through G2/M cell cycle arrest

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12672-012-0114-X

Apigenin inhibits proliferation and induces apoptosis in human multiple myeloma cells through targeting the trinity of CK2, Cdc37 and Hsp90

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12672-012-0114-X

Characterization of androgen receptor and nuclear receptor co-regulator expression in human breast cancer cell lines exhibiting differential regulation of kallikreins 2 and 3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12672-012-0114-X

Vascular endothelial growth factor mediates intracrine survival in human breast carcinoma cells through internally expressed VEGFR1/FLT1

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12672-012-0114-X

The role of the VEGF-C/VEGFR-3 axis in cancer progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12672-012-0114-X

Classical membrane progesterone receptors in murine mammary carcinomas: agonistic effects of progestins and RU-486 mediating rapid non-genomic effects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12672-012-0114-X

A local basis for progesterone action during mammary tumorigenesis - no longer RANK and file

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12672-012-0114-X

High hopes for RANKL: will the mouse model live up to its promise?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12672-012-0114-X

Strain-specific differences in the mechanisms of progesterone regulation of murine mammary gland development

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12672-012-0114-X

Selective growth-inhibitory, cell-cycle deregulatory and apoptotic response of apigenin in normal versus human prostate carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12672-012-0114-X

Progestins and breast cancer

21 January 2018

1 reference

12 December 2020

Estrogen and progesterone receptors: from molecular structures to clinical targets

1 reference

12 December 2020

Apigenin and cancer chemoprevention: progress, potential and promise (review).

1 reference

12 December 2020

Effect of overexpression of progesterone receptor A on endogenous progestin-sensitive endpoints in breast cancer cells

1 reference

12 December 2020

Effects of estrogen-progestin therapy on serum levels of RANKL, osteoprotegerin, osteocalcin, leptin, and ghrelin in postmenopausal women

1 reference

12 December 2020

Progestin regulation of vascular endothelial growth factor in human breast cancer cells

1 reference

12 December 2020

Antiprogestins, a new form of endocrine therapy for human breast cancer

1 reference

12 December 2020

Serum from rabbit orally administered cobra venom inhibits growth of implanted hepatocellular carcinoma cells in mice

1 reference

12 December 2020

Apigenin suppresses the growth of colorectal cancer xenografts via phosphorylation and up-regulated FADD expression

1 reference

12 December 2020

Estrogen Plus Progestin and Breast Cancer Incidence and Mortality in Postmenopausal Women

1 reference

12 December 2020

Natural and synthetic progestins accelerate 7,12-dimethylbenz[a]anthracene-initiated mammary tumors and increase angiogenesis in Sprague-Dawley rats

1 reference

12 December 2020

UCN-01 suppresses thymidylate synthase gene expression and enhances 5-fluorouracil-induced apoptosis in a sequence-dependent manner.

1 reference

12 December 2020

Cisplatin-induced apoptosis proceeds by caspase-3-dependent and -independent pathways in cisplatin-resistant and -sensitive human ovarian cancer cell lines.

1 reference

12 December 2020

10.1007/S12672-012-0114-X

Identifiers

DOI

1 reference

11 September 2017

1 reference